市場調査レポート
商品コード
1593498

ボトックスの市場規模・シェア・成長分析 (製品種類別、用途別、エンドユーザー別、地域別):産業予測 (2024~2031年)

Botox Market Size, Share, Growth Analysis, By Product Type (Type A, Type B), By Application (Therapeutic, Aesthetic), By End User (Hospitals, Clinics / Med Spas and Dermatology / Cosmetology Centers), By Region - Industry Forecast 2024-2031


出版日
発行
SkyQuest
ページ情報
英文 175 Pages
納期
3~5営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=145.94円
ボトックスの市場規模・シェア・成長分析 (製品種類別、用途別、エンドユーザー別、地域別):産業予測 (2024~2031年)
出版日: 2024年11月13日
発行: SkyQuest
ページ情報: 英文 175 Pages
納期: 3~5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

世界のボトックスの市場規模は、2022年に41億米ドルと評価され、2023年の45億2,000万米ドルから2031年には98億3,000万米ドルに成長し、予測期間 (2024~2031年) のCAGRは10.20%に達する見通しです。

ボトックスの世界市場は、医療・美容の両分野における多目的な用途に牽引され、力強い成長を遂げています。ボツリヌス菌由来のタンパク質・神経毒であるボトックスは、注射により神経伝達を効果的に遮断するため、低侵襲の美容施術に人気があります。先進国・新興国における美容整形の需要拡大は、侵襲性の低い手術に対する消費者の嗜好の高まりと相まって、市場拡大に拍車をかけています。痛みの軽減、入院期間の短縮、感染リスクの低下といった利点が、その魅力をさらに高めています。さらに、治療法の進歩、手頃な価格、有利な償還政策が採用を後押ししています。市場各社は、進化する消費者ニーズに対応するため、技術革新や製品の更新に注力しており、美容・医療におけるボトックスの地位を確固たるものにしています。

目次

イントロダクション

  • 分析目的
  • 定義
  • 市場範囲

分析手法

  • 情報調達
  • 二次データソースと一次データソース
  • 市場規模予測
  • 市場の想定と制限

エグゼクティブサマリー

  • 市場の概要と見通し
  • 需給動向の分析
  • セグメント別の機会分析

市場力学と見通し

  • 市場力学
    • 促進要因
    • 機会
    • 抑制要因
    • 課題
  • ポーターの分析

主な市場の考察

  • 技術分析
  • バリューチェーン分析
  • 市場のエコシステム
  • ケーススタディ分析
  • 規制情勢
  • 主な投資の分析
  • 主な成功要因
  • 競合の程度
  • 原材料の分析
  • 価格分析
  • PESTEL分析

ボトックス市場:製品種類別

  • 市場概要
  • タイプA
    • Dysport
    • Xeomin
    • Daxxify
    • その他
  • タイプB

ボトックス市場:用途別

  • 市場概要
  • 治療的
    • 慢性片頭痛
    • 過活動膀胱
    • 頸部ジストニア
    • 痙縮
    • その他
  • 美的
    • 眉間のしわ
    • 目尻のしわ
    • 額のしわ
    • その他

ボトックス市場:エンドユーザー別

  • 市場概要
  • 病院
  • クリニック/医療スパ、皮膚科/美容センター
  • その他のエンドユーザー

ボトックス市場:地域別

  • 市場概要
  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • スペイン
    • フランス
    • 英国
    • イタリア
    • その他欧州
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋
  • ラテンアメリカ
    • ブラジル
    • その他ラテンアメリカ
  • 中東・アフリカ (MEA)
    • 湾岸協力会議 (GCC) 諸国
    • 南アフリカ
    • その他中東・アフリカ

競合情勢

  • 上位5社の比較
  • 主要企業の市場ポジショニング (2023年)
  • 主な市場企業が採用した戦略
  • 市場における最近の活動
  • 主要企業の市場シェア (2023年)

主要企業プロファイル

  • Croma Pharma (オーストリア)
  • Dermosistemi (イタリア)
  • Koru Pharma (トルコ)
  • Love Cosmedical (オーストラリア)
  • MedicalZone (トルコ)
  • Merz Pharma (ドイツ)
  • MesoTech (イタリア)
  • NeoGenesis (米国)
  • Nyuma Pharma (トルコ)
  • Xcelene (米国)
  • Revvity, Inc (米国)
  • Cellerant Therapeutics, Inc. (米国)
  • StemCell Technologies Inc. (カナダ)
  • Regenexx (米国)
  • Mesoblast Limited (オーストラリア)
  • OrthoGenics (米国)
  • Panthera Biopartners (英国)
  • Stemson Therapeutics (米国)
  • Lonza Group AG (スイス)
  • Macopharma (フランス)
  • Cure Cell (トルコ)
  • Celularity (米国)
目次
Product Code: SQMIG35H2296

Global Botox Market size was valued at USD 4.1 billion in 2022 and is poised to grow from USD 4.52 billion in 2023 to USD 9.83 billion by 2031, growing at a CAGR of 10.20% during the forecast period (2024-2031).

The global Botox market is witnessing robust growth, driven by its versatile applications in both medical and cosmetic treatments. Botox, a protein and neurotoxin derived from Clostridium botulinum, effectively blocks neural transmissions when injected, making it a popular choice for minimally invasive cosmetic procedures. Rising demand for aesthetic enhancements in developed and developing economies, coupled with growing consumer preference for less invasive surgeries, is fueling market expansion. Benefits such as reduced pain, shorter hospital stays, and lower infection risks are further enhancing its appeal. Additionally, advancements in therapeutics, affordability, and favorable reimbursement policies are propelling adoption. Market players are focusing on innovation and product upgrades to cater to evolving consumer needs, solidifying Botox's position in aesthetic and medical care.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Botox market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Botox Market Segmental Analysis

Global Botox Market is segmented by Product Type, Application, End User, and region. Based on Product Type, the market is segmented into Type A (Dysport, Xeomin, Daxxify, Others), Type B. Based on Application, the market is segmented into Therapeutic (Chronic Migraine, Overactive Bladder, Cervical Dystonia, Spasticity, Others), Aesthetic (Glabellar Lines, Crow's Feet, Forehead Lines, Others). Based on End User, the market is segmented into Hospitals, Clinics / Med Spas and Dermatology / Cosmetology Centers, and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Global Botox Market

The global Botox market is witnessing significant growth driven by the rising demand for cosmetic procedures worldwide. Changing societal norms and an increasing preference for non-surgical, minimally invasive treatments have fueled the popularity of Botox injections. These procedures are widely embraced for their ability to enhance physical appearance by effectively reducing wrinkles and fine lines, offering a convenient and less invasive alternative to traditional surgical methods. As individuals increasingly prioritize aesthetic improvements and youthful looks, the adoption of Botox treatments continues to expand across diverse demographics, cementing its position as a key player in the cosmetic industry.

Restraints in the Global Botox Market

One of the significant restraints in the global Botox market is the high cost associated with treatments, particularly for cosmetic procedures. Since Botox injections used for aesthetic purposes are typically not covered by insurance, they remain financially out of reach for many individuals. This lack of affordability limits the market's accessibility to a broader demographic, creating a substantial barrier to growth. As a result, the high expense of these procedures continues to challenge market expansion, particularly in regions where disposable incomes are lower and financial constraints are more pronounced. This financial barrier underscores a critical obstacle for the widespread adoption of Botox treatments, hindering the market's overall development potential.

Market Trends of the Global Botox Market

A prominent trend in the global Botox market is the increasing adoption of Botox injections as a preventive measure among the younger generation. Individuals in their twenties and thirties are increasingly opting for Botox to delay the onset of wrinkles and fine lines, significantly broadening the market's consumer base and fueling growth. Additionally, the growing therapeutic applications of Botox are driving demand. Its effectiveness in treating various medical conditions, including chronic migraines, muscle disorders, and excessive sweating, underscores its versatility and appeal. This dual trend of cosmetic and therapeutic utilization is reshaping the market dynamics, fostering innovation, and accelerating market expansion globally.

Table of Contents

Introduction

  • Objectives of the Study
  • Definitions
  • Market Scope

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Sources
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Market Overview Outlook
  • Supply Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of Substitute Products
    • Bargaining Power of Buyers
    • Threat of New Entrants
    • Bargaining Power of Suppliers

Key Market Insights

  • Technology Analysis
  • Value Chain Analysis
  • Ecosystem of the Market
  • Case study Analysis
  • Regulatory Landscape
  • Top Investment Analysis
  • Key Success Factor
  • Degree of Competition
  • Raw Material Analysis
  • Pricing Analysis
  • PESTEL Analysis

Botox Market by Product Type

  • Market Overview
  • Type A
    • Dysport
    • Xeomin
    • Daxxify
    • Others
  • Type B

Botox Market by Application

  • Market Overview
  • Therapeutic
    • Chronic Migraine
    • Overactive Bladder
    • Cervical Dystonia
    • Spasticity
    • Others
  • Aesthetic
    • Glabellar Lines
    • Crow's Feet
    • Forehead Lines
    • Others

Botox Market by End User

  • Market Overview
  • Hospitals
  • Clinics / Med Spas and Dermatology / Cosmetology Centers
  • Other End Users

Botox Market Size by Region

  • Market Overview
  • North America
    • USA
    • Canada
  • Europe
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC Countries
    • South Africa
    • Rest of MEA

Competitive Landscape

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2023
  • Strategies Adopted by Key Market Players
  • Recent Activities in the Market
  • Key Companies Market Share (%), 2023

Key Company Profiles

  • Croma Pharma (Austria)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Dermosistemi (Italy)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Koru Pharma (Turkey)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Love Cosmedical (Australia)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • MedicalZone (Turkey)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Merz Pharma (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • MesoTech (Italy)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • NeoGenesis (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Nyuma Pharma (Turkey)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Xcelene (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Revvity, Inc (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cellerant Therapeutics, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • StemCell Technologies Inc. (Canada)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Regenexx (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Mesoblast Limited (Australia)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • OrthoGenics (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Panthera Biopartners (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Stemson Therapeutics (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Lonza Group AG (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Macopharma (France)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cure Cell (Turkey)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Celularity (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments